Relationship between adrenomedullin and left-ventricular systolic function and mortality in acute myocardial infarction

Angiology

Volumn 56, Issue 1, 2005, Pages 35-42

  Katayama, Toshiro ^a,b,c   Nakashima, Hiroshi ^a,b   Honda, Yukiharu ^a,b   Suzuki, Shin ^a,b   Yano, Katsusuke ^a,c  

^a Nagasaki Citizens Hospital ^*

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENOMEDULLIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; HEPARIN; LIDOCAINE; LOSARTAN; NICORANDIL; QUINAPRIL; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY REPERFUSION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK ASSESSMENT; SYSTOLE;

ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDES; PROGNOSIS; STATISTICS; STROKE VOLUME; SURVIVAL ANALYSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 12944283138     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600105     Document Type: Article

References (23)

1. Kitamura K, Kangawa K, Kawamoto, et al: Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560, 1993.
2. Ichiki Y, Kitamura K, Kangawa K, et al: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338:6-10, 1994.
3. Nishikimi T, Saito Y, Kitamura K, et al: Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 26:1424-1431, 1995.
4. Ishimitsu T, Nishikimi T, Saito Y, et al: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94:2158-2161, 1994.
5. Nishikimi T, Horio T, Sasaki T, et al: Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension 30:1369-1375, 1997.
6. Yoshitomi Y, Nishikimi T, Kojima S, et al: Plasma levels of adrenomedullin in patients with acute myocardial infarction. Clinical Science 94:135-139, 1998.
7. Nagaya N, Nishikimi T, Uematsu M, et al: Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart 81:483-487, 1999.
8. Miyao Y, Nishikimi T, Goto Y, et al: Increased plasma adrenomedullin levels in patients with acute myocardial infarction. Heart 79:39-44, 1998.
9. Ishiyama Y, Kitamura K, Ichiki Y, et al: Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 241:271-273, 1993.
10. Kitamura K, Ichiki Y, Tanaka M, et al: Immunoreactive adrenomedullin in human plasma. FEBS Lett 341:288-290, 1994.
11. Nishikimi T, Nagata S, Sasaki T, et al: Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart 78:390-395, 1997.
12. Sumitomo T, Nishikimi T, Mukai M, et al: Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 30:741-745, 1997.
13. Jougasaki M, Wei CM, McKinley LJ, et al: Elevation circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92:286-289, 1995.
14. Jougasaki M, Rodeheffer RJ, Redfield MM, et al: Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 97:2370-2376, 1996.
15. Kobayashi K, Kitamura K, Hirayama N, et al: Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 131:676-680, 1996.
16. Nagaya N, Goto Y, Satoh T, et al: Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol 39:754-760, 2002.
17. Cao J, Zhang J, Wang X: Changes and cardiac protective effects of adrenomedullin during myocardial ischemia-reperfusion period. Zhonghua Yi Xue Za Zhi 80:261-264, 2000.
18. Morrow DA, Rifai N, Antman EM, et al: Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 35:358-362, 2000.
19. Anzai T, Yoshikawa T, Shiraki H, et al: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96:778-784, 1997.
20. Liuzzo G, Biasucci LM, Gallimore JR, et al: Enhanced inflammatory responde in patients with preinfarctional unstable angina. J Am Coll Cardiol 34:1696-1703, 1999.
21. Ehlentz K, Koch B, Preuss P, et al: High levels of circulating adrenomedullin in severe illness: Correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 105:156-162, 1997.
22. Richards AM, Nicholls MG, Yandle TG, et al: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97:1921-1929, 1998.
23. Nakamura R, Kato J, Kitamura K, et al: Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats. Cardiovasc Res 56:373-380, 2002.